These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26476407)

  • 1. DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency.
    Volk T; Pannicke U; Reisli I; Bulashevska A; Ritter J; Björkman A; Schäffer AA; Fliegauf M; Sayar EH; Salzer U; Fisch P; Pfeifer D; Di Virgilio M; Cao H; Yang F; Zimmermann K; Keles S; Caliskaner Z; Güner SÜ; Schindler D; Hammarström L; Rizzi M; Hummel M; Pan-Hammarström Q; Schwarz K; Grimbacher B
    Hum Mol Genet; 2015 Dec; 24(25):7361-72. PubMed ID: 26476407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.
    Felgentreff K; Lee YN; Frugoni F; Du L; van der Burg M; Giliani S; Tezcan I; Reisli I; Mejstrikova E; de Villartay JP; Sleckman BP; Manis J; Notarangelo LD
    J Allergy Clin Immunol; 2015 Jul; 136(1):140-150.e7. PubMed ID: 25917813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The most frequent DCLRE1C (ARTEMIS) mutations are based on homologous recombination events.
    Pannicke U; Hönig M; Schulze I; Rohr J; Heinz GA; Braun S; Janz I; Rump EM; Seidel MG; Matthes-Martin S; Soerensen J; Greil J; Stachel DK; Belohradsky BH; Albert MH; Schulz A; Ehl S; Friedrich W; Schwarz K
    Hum Mutat; 2010 Feb; 31(2):197-207. PubMed ID: 19953608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The many faces of Artemis-deficient combined immunodeficiency - Two patients with DCLRE1C mutations and a systematic literature review of genotype-phenotype correlation.
    Lee PP; Woodbine L; Gilmour KC; Bibi S; Cale CM; Amrolia PJ; Veys PA; Davies EG; Jeggo PA; Jones A
    Clin Immunol; 2013 Dec; 149(3):464-74. PubMed ID: 24230999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemis splice defects cause atypical SCID and can be restored in vitro by an antisense oligonucleotide.
    Ijspeert H; Lankester AC; van den Berg JM; Wiegant W; van Zelm MC; Weemaes CM; Warris A; Pan-Hammarström Q; Pastink A; van Tol MJ; van Dongen JJ; van Gent DC; van der Burg M
    Genes Immun; 2011 Sep; 12(6):434-44. PubMed ID: 21390052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective Artemis nuclease is characterized by coding joints with microhomology in long palindromic-nucleotide stretches.
    van der Burg M; Verkaik NS; den Dekker AT; Barendregt BH; Pico-Knijnenburg I; Tezcan I; vanDongen JJ; van Gent DC
    Eur J Immunol; 2007 Dec; 37(12):3522-8. PubMed ID: 18034425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T-lymphocyte-associated protein 4-Ig effectively controls immune activation and inflammatory disease in a novel murine model of leaky severe combined immunodeficiency.
    Humblet-Baron S; Schönefeldt S; Garcia-Perez JE; Baron F; Pasciuto E; Liston A
    J Allergy Clin Immunol; 2017 Nov; 140(5):1394-1403.e8. PubMed ID: 28185879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe combined immunodeficiency (SCID) presenting in childhood, with agammaglobulinemia, associated with novel compound heterozygous mutations in DCLRE1C.
    Sundin M; Marits P; Ramme K; Kolios AGA; Nilsson J
    Clin Immunol; 2019 Mar; 200():16-18. PubMed ID: 30630113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.
    Punwani D; Kawahara M; Yu J; Sanford U; Roy S; Patel K; Carbonaro DA; Karlen AD; Khan S; Cornetta K; Rothe M; Schambach A; Kohn DB; Malech HL; McIvor RS; Puck JM; Cowan MJ
    Hum Gene Ther; 2017 Jan; 28(1):112-124. PubMed ID: 27611239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound heterozygous DCLRE1C mutations lead to clinically typical Severe Combined Immunodeficiency presenting with Graft Versus Host Disease.
    Mou W; Gao L; He J; Yin J; Xu B; Gui J
    Immunogenetics; 2021 Dec; 73(6):425-434. PubMed ID: 34406419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Non-Coding Variant in DCLRE1C Results in Deregulated Splicing and Induces SCID Through the Generation of a Truncated ARTEMIS Protein That Fails to Support V(D)J Recombination and DNA Damage Repair.
    Strubbe S; De Bruyne M; Pannicke U; Beyls E; Vandekerckhove B; Leclercq G; De Baere E; Bordon V; Vral A; Schwarz K; Haerynck F; Taghon T
    Front Immunol; 2021; 12():674226. PubMed ID: 34220820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual phenotype in patients with a hypomorphic mutation in the DCLRE1C gene: IgG hypergammaglobulinemia with IgA and IgE deficiency.
    Nahum A; Somech R; Shubinsky G; Levy J; Broides A
    Clin Immunol; 2020 Apr; 213():108366. PubMed ID: 32092471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis.
    Moshous D; Pannetier C; Chasseval Rd Rd; Deist Fl Fl; Cavazzana-Calvo M; Romana S; Macintyre E; Canioni D; Brousse N; Fischer A; Casanova JL; Villartay JP
    J Clin Invest; 2003 Feb; 111(3):381-7. PubMed ID: 12569164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical combined immunodeficiency due to Artemis defect: a case presenting as hyperimmunoglobulin M syndrome and with LGLL.
    Bajin İY; Ayvaz DÇ; Ünal S; Özgür TT; Çetin M; Gümrük F; Tezcan İ; de Villartay JP; Sanal Ö
    Mol Immunol; 2013 Dec; 56(4):354-7. PubMed ID: 23911390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced immunoglobulin class switch recombination in the absence of Artemis.
    Rivera-Munoz P; Soulas-Sprauel P; Le Guyader G; Abramowski V; Bruneau S; Fischer A; Pâques F; de Villartay JP
    Blood; 2009 Oct; 114(17):3601-9. PubMed ID: 19692705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
    IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
    J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of T-B-NK+ severe combined immunodeficiency and Omenn syndrome cases in Saudi Arabia.
    Alsmadi O; Al-Ghonaium A; Al-Muhsen S; Arnaout R; Al-Dhekri H; Al-Saud B; Al-Kayal F; Al-Saud H; Al-Mousa H
    BMC Med Genet; 2009 Nov; 10():116. PubMed ID: 19912631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel spontaneous deletion of artemis exons 10 and 11 in mice leads to T- and B-cell deficiency.
    Barthels C; Puchałka J; Racek T; Klein C; Brocker T
    PLoS One; 2013; 8(9):e74838. PubMed ID: 24069355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV.
    Buck D; Moshous D; de Chasseval R; Ma Y; le Deist F; Cavazzana-Calvo M; Fischer A; Casanova JL; Lieber MR; de Villartay JP
    Eur J Immunol; 2006 Jan; 36(1):224-35. PubMed ID: 16358361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omenn syndrome due to ARTEMIS mutations.
    Ege M; Ma Y; Manfras B; Kalwak K; Lu H; Lieber MR; Schwarz K; Pannicke U
    Blood; 2005 Jun; 105(11):4179-86. PubMed ID: 15731174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.